Work to minimize environmental and lifestyle contributors
Expanding the range of treatment indications and clinical use: Oral GLP-1 agonists are being utilized more broadly in a wider range of indications than solely T2D
The concern stems from the fact that these drugs promote cellular proliferation in the intestines, potentially leading to tumorigenesis
The KD may be especially beneficial in women with obesity and endometriosis, who often present with an altered metabolic phenotype with insulin resistance, chronic inflammation, and increased peripheral aromatization of androgens into estrogens in adipose tissue by aromatases
This condition is found in 14% worldwide, affecting all demographics, with higher prevalence in women, the elderly, and lower socioeconomic groups [2], making it the sixth most common gastrointestinal issue and causing a large social burden [3, 4]
If BPC-157 doesnt trigger your snake-oil antenna then nothing will